To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(15 sites)

China

China-Japan Friendship Hospital, Beijing, Beijing Municipality

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong

The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan

Henan Provincial People's Hospital, Zhengzhou, Henan

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Wuhan Central Hospital, Wuhan, Hubei

Xiangtan Central Hospital, Xiangtan, Hunan

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi

Weifang People's Hospital, Weifang, Shandong

Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan

Dazhou Central Hospital, Dazhou, Sichuan

Hangzhou First People's Hospital, Hangzhou, Zhejiang